RPRX · Royalty Pharma plc · Documents

$63.86 +0.11 (+0.17%) At close · Oct 23

Market Cap

$36.72B

575.00M

Volume · Oct 23 4.02M Avg daily vol (3M) 3M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
10-Q	—	2022-05-05	2022-03-31
8-K	—	2022-05-05	—
DEFA14A	—	2022-04-28	—
DEF 14A	—	2022-04-28	2022-06-23
8-K	—	2022-04-15	—
8-K	—	2022-04-04	2022-04-01
8-K	—	2022-02-15	—
10-K	—	2022-02-15	2021-12-31
8-K	—	2022-01-10	—
10-Q	—	2021-11-10	2021-09-30
8-K	—	2021-11-10	—
10-Q	—	2021-08-11	2021-06-30
8-K	—	2021-08-11	—
8-K	—	2021-07-26	—
8-K	—	2021-07-16	2021-07-15
S-3ASR	—	2021-07-14	—
S-4/A	—	2021-07-02	—
8-K	—	2021-06-25	2021-06-24
S-4	—	2021-06-21	—
8-K	—	2021-06-02	—
10-Q	—	2021-05-11	2021-03-31
8-K	—	2021-05-11	—
DEFA14A	—	2021-04-29	—
DEF 14A	—	2021-04-29	2021-06-24
10-K	—	2021-02-24	2020-12-31
8-K	—	2021-02-17	—
8-K	—	2021-02-03	—
10-Q	—	2020-11-12	2020-09-30
8-K	—	2020-11-10	—
8-K	—	2020-11-05	2020-10-30
S-1	—	2020-10-13	—
8-K	—	2020-09-02	—
8-K	—	2020-08-19	—
10-Q	—	2020-08-12	2020-06-30
8-K	—	2020-08-12	—
8-K	—	2020-08-03	2020-07-30
8-K/A	—	2020-08-03	2020-07-30
8-K	—	2020-07-14	—
8-K	—	2020-06-19	2020-06-16
S-1/A	—	2020-06-11	—
S-1/A	—	2020-06-08	—
S-1/A	—	2020-06-02	—
S-1	—	2020-05-22	—

Showing 101–143 of 143 filings

Key facts CIK 1802768 CUSIP G7709Q104 13F (30d) 142 filings 130 filers Visit website Investor relations